IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although direct effects of IFN on CML cells have been described as a mechanism of inducing remission, how this remission is maintained in the absence of continuous IFN treatment in patients with persistent molecular disease remains unknown.